Ticker
BEAMCompany Name
BEAM THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -398.58M | $ -3.91 | 1 | 102M |
3/31/2025 | $ -387.3M | $ -4.4 | 1 | 87.98M |
12/31/2024 | $ -376.7M | $ -4.58 | 1 | 82.31M |
9/30/2024 | $ -142.19M | $ -1.73 | 1 | 82.41M |
6/30/2024 | $ -141.61M | $ -1.72 | 1 | 82.31M |
3/31/2024 | $ -133.37M | $ -1.63 | 1 | 81.7M |
12/31/2023 | $ -131.16M | $ -1.7 | 1 | 77.15M |
9/30/2023 | $ -312.67M | $ -3.96 | 1 | 79.02M |
6/30/2023 | $ -323.75M | $ -4.24 | 1 | 76.34M |
3/31/2023 | $ -312.92M | $ -4.33 | 1 | 72.27M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for BEAM THERAPEUTICS INC is calculated as follows: EBIT [ $ -126.86M ] / (Shares WA [ 50.09M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -2.53 ]
Minimum
Jun 30, 2021
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.72 |
max | $ 10.76 |
average | $ 1.16 |
median | $ 0.39 |
std | $ 3.42 |